Nanomedicine, Volume IIA: Biocompatibility
© 2003 Robert A. Freitas Jr. All Rights Reserved.
Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003
5100. A.W. Bosman, H.M. Janssen, E.W. Meijer. “About dendrimers: Structure, physical properties, and applications,” Chem. Rev. 99(14 July 1999):1665-1688.
5101. M. Liu, J.M. Frechet, “Designing dendrimers for drug delivery,” Pharm. Sci. Technol. Today 2(October 1999):393-401.
5102. S.M. Grayson, J.M. Frechet, “Convergent dendrons and dendrimers: from synthesis to applications,” Chem. Rev. 101(December 2001):3819-3868.
5103. B. Klajnert, M. Bryszewska, “Dendrimers: properties and applications,” Acta Biochim. Pol. 48(2001):199-208.
5104. F. Diederich, B. Felber, “Supramolecular chemistry and self-assembly special feature: Supramolecular chemistry of dendrimers with functional cores,” Proc. Natl. Acad. Sci. (USA) 99(16 April 2002):4778-4781.
5105. J.M. Frechet, “Supramolecular chemistry and self-assembly special feature: Dendrimers and supramolecular chemistry,” Proc. Natl. Acad. Sci. (USA) 99(16 April 2002):4782-4787.
5106. A.U. Bielinska, J.F. Kukowska-Latallo, J.R. Baker Jr., “The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA,” Biochim. Biophys. Acta 1353(7 August 1997):180-190; A.U. Bielinska, C. Chen, J. Johnson, J.R. Baker Jr., “DNA complexing with polyamidoamine dendrimers: implications for transfection,” Bioconjug. Chem. 10(September-October 1999):843-850.
5107. D. Wang, J.P. Kopeckova, T. Minko, V. Nanayakkara, J. Kopecek, “Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers,” Biomacromolecules 1(Fall 2000):313-319.
5108. O. Pillai, R. Panchagnula, “Polymers in drug delivery,” Curr. Opin. Chem. Biol. 5(August 2001):447-451.
5109. J. Haensler, F.C. Szoka Jr., “Polyamidoamine cascade polymers mediate efficient transfection of cells in culture,” Bioconjug. Chem. 4(September-October 1993):372-379.
5110. J.F. Kukowska-Latallo, A.U. Bielinska, J. Johnson, R. Spindler, D.A. Tomalia, J.R. Baker Jr., “Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers,” Proc. Natl. Acad. Sci. (USA) 93(14 May 1996):4897-4902; http://www.pnas.org/cgi/reprint/93/10/4897
5111. M.X. Tang, C.T. Redemann, F.C. Szoka Jr., “In vitro gene delivery by degraded polyamidoamine dendrimers,” Bioconjug. Chem. 7(November-December 1996):703-714.
5112. L. Qin, D.R. Pahud, Y. Ding, A.U. Bielinska, J.F. Kukowska-Latallo, J.R. Baker Jr., J.S. Bromberg, “Efficient transfer of genes into murine cardiac grafts by Starburst polyamidoamine dendrimers,” Hum. Gene Ther. 9(1 March 1998):553-560.
5113. T. Hudde, S.A. Rayner, R.M. Comer, M. Weber, J.D. Isaacs, H. Waldmann, D.F. Larkin, A.J. George, “Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium,” Gene Ther. 6(May 1999):939-943.
5114. V. Helin, M. Gottikh, Z. Mishal, F. Subra, C. Malvy, M. Lavignon, “Uptake and intracellular distribution of oligonucleotides vectorized by a PAMAM dendrimer,” Nucleosides Nucleotides 18(June-July 1999):1721-1722.
5115. C.B. Mamoun, R. Truong, I. Gluzman, N.S. Akopyants, A. Oksman, D.E. Goldberg, “Transfer of genes into Plasmodium falciparum by polyamidoamine dendrimers,” Mol. Biochem. Parasitol. 103(20 September 1999):117-121.
5116. D.S. Howard, D.A. Rizzierri, B. Grimes, D. Upchurch, G.L. Phillips, A.K. Stewart, J.R. Yannelli, C.T. Jordan, “Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer,” Leukemia 13(October 1999):1608-1616.
5117. J.F. Kukowska-Latallo, C. Chen, J. Eichman, A.U. Bielinska, J.R. Baker Jr., “Enhancement of dendrimer-mediated transfection using synthetic lung surfactant exosurf neonatal in vitro,” Biochem. Biophys. Res. Commun. 264(14 October 1999):253-261.
5118. A.U. Bielinska, A. Yen, H.L. Wu, K.M. Zahos, R. Sun, N.D. Weiner, J.R. Baker Jr., B.J. Roessler, “Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo,” Biomaterials 21(May 2000):877-887.
5119. J.F. Kukowska-Latallo, E. Raczka, A. Quintana, C. Chen, M. Rymaszewski, J.R. Baker Jr., “Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector,” Hum. Gene Ther. 11(1 July 2000):1385-1395.
5120. J.D. Eichman, A.U. Bielinska, J.F. Kukowska-Latallo, J.R. Baker Jr., “The use of PAMAM dendrimers in the efficient transfer of genetic material into cells,” Pharm. Sci. Technol. Today 3(July 2000):232-245.
5121. D.S. Shah, T. Sakthivel, I. Toth, A.T. Florence, A.F. Wilderspin, “DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers,” Int. J. Pharm. 208(4 November 2000):41-48.
5122. Y. Wang, P. Boros, J. Liu, L. Qin, Y. Bai, A.U. Bielinska, J.F. Kukowska-Latallo, J.R. Baker Jr., J.S. Bromberg, “DNA/dendrimer complexes mediate gene transfer into murine cardiac transplants ex vivo,” Mol. Ther. 2(December 2000):602-608.
5123. H. Cheng, R. Zhou, L. Liu, B. Du, R. Zhuo, “Cyclic core dendrimer as a new kind of vector for gene transfer into mammalian cells,” Genetica 108(2000):53-56.
5124. B.J. Roessler, A.U. Bielinska, K. Janczak, I. Lee, J.R. Baker Jr., “Substituted beta-cyclodextrins interact with PAMAM dendrimer-DNA complexes and modify transfection efficiency,” Biochem. Biophys. Res. Commun. 283(27 April 2001):124-129.
5125. C.L. Gebhart, A.V. Kabanov, “Evaluation of polyplexes as gene transfer agents,” J. Control Release 73(15 June 2001):401-416.
5126. S. Ohashi, T. Kubo, T. Ikeda, Y. Arai, K. Takahashi, Y. Hirasawa, M. Takigawa, E. Satoh, J. Imanishi, O. Mazda, “Cationic polymer-mediated genetic transduction into cultured human chondrosarcoma-derived HCS-2/8 cells,” J. Orthop. Sci. 6(2001):75-81.
5127. G. de Jong, A. Telenius, S. Vanderbyl, A. Meitz, J. Drayer, “Efficient in-vitro transfer of a 60-Mb mammalian artificial chromosome into murine and hamster cells using cationic lipids and dendrimers,” Chromosome Res. 9(2001):475-485.
5128. J.C. Roberts, Y.E. Adams, D. Tomalia, J.A. Mercer-Smith, D.K. Lavallee, “Using starburst dendrimers as linker molecules to radiolabel antibodies,” Bioconjug. Chem. 1(September-October 1990):305-308.
5129. E.C. Wiener, M.W. Brechbiel, H. Brothers, R.L. Magin, O.A. Gansow, D.A. Tomalia, P.C. Lauterbur, “Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents,” Magn. Reson. Med. 31(January 1994):1-8.
5130. E.C. Wiener, S. Konda, A. Shadron, M. Brechbiel, O. Gansow, “Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor,” Invest. Radiol. 32(December 1997):748-754.
5131. S. Kim, J.H. Kim, W.K. Moon, B.G. Min, “Lesion characterization using vessel permeability map to new blood pool contrast agent calculated from dynamic magnetic resonance images,” J. Digit. Imaging 13(May 2000):193-195.
5132. H. Kobayashi, N. Sato, S. Kawamoto, T. Saga, A. Hiraga, T. Ishimori, J. Konishi, K. Togashi, M.W. Brechbiel, “Novel intravascular macromolecular MRI contrast agent with generation-4 polyamidoamine dendrimer core: accelerated renal excretion with coinjection of lysine,” Magn. Reson. Med. 46(September 2001):457-464.
5133. H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, T. Ishimori, J. Konishi, K. Togashi, M.W. Brechbiel, “Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents,” Magn. Reson. Med. 46(October 2001):781-788.
5134. H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, T. Ishimori, Y. Akita, M.H. Mamede, J. Konishi, K. Togashi, M.W. Brechbiel, “Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core,” Magn. Reson. Med. 46(October 2001):795-802.
5135. N. Sato, H. Kobayashi, A. Hiraga, T. Saga, K. Togashi, J. Konishi, M.W. Brechbiel, “Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores,” Magn. Reson. Med. 46(December 2001):1169-1173.
5136. H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, J. Konishi, K. Togashi, M.W. Brechbiel, “Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: reference to pharmacokinetic properties of dendrimer-based MR contrast agents,” J. Magn. Reson. Imaging 14(December 2001):705-713.
5137. G.M. Nicolle, E. Toth, H. Schmitt-Willich, B. Raduchel, A.E. Merbach, “The impact of rigidity and water exchange on the relaxivity of a dendritic MRI contrast agent,” Chemistry 8(1 March 2002):1040-1048.
5138. S.D. Konda, S. Wang, M. Brechbiel, E.C. Wiener, “Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenografts,” Invest. Radiol. 37(April 2002):199-204.
5139. R. Roy, M.G. Baek, K. Rittenhouse-Olson, “Synthesis of N,N’-bis(acrylamido)acetic acid-based T-antigen glycodendrimers and their mouse monoclonal IgG antibody binding properties,” J. Am. Chem. Soc. 123(7 March 2001):1809-1816; J. Gerhart, M. Baytion, S. DeLuca, R. Getts, C. Lopez, R. Niewenhuis, T. Nilsen, S. Olex, H. Weintraub, M. George-Weinstein, “DNA dendrimers localize MyoD mRNA in presomitic tissues of the chick embryo,” J. Cell Biol. 149(15 May 2000):825-834; http://www.jcb.org/cgi/content/full/149/4/825
5140. P. Singh, F. Moll 3rd, S.H. Lin, C. Ferzli, K.S. Yu, R.K. Koski, R.G. Saul, P. Cronin, “Starburst dendrimers: enhanced performance and flexibility for immunoassays,” Clin. Chem. 40(September 1994):1845-1849.
5141. R.J. Orentas, S.J. Rospkopf, J.T. Casper, R.C. Getts, T.W. Nilsen, “Detection of Epstein-Barr virus EBER sequence in post-transplant lymphoma patients with DNA dendrimers,” J. Virol. Methods 77(February 1999):153-163.
5142. T.S. Snowden, E.V. Anslyn, “Anion recognition: synthetic receptors for anions and their application in sensors,” Curr. Opin. Chem. Biol. 3(December 1999):740-746.
5143. H.C. Yoon, H.S. Kim, “Multilayered assembly of dendrimers with enzymes on gold: thickness-controlled biosensing interface,” Anal. Chem. 72(1 March 2000):922-926.
5144. H.C. Yoon, M.Y. Hong, H.S. Kim, “Affinity biosensor for avidin using a double functionalized dendrimer monolayer on a gold electrode,” Anal. Biochem. 282(15 June 2000):121-128.
5145. A.C. Chang, J.B. Gillespie, M.B. Tabacco, “Enhanced detection of live bacteria using a dendrimer thin film in an optical biosensor,” Anal. Chem. 73(1 February 2001):467-470.
5146. D. de Groot, B.F. de Waal, J.N. Reek, A.P. Schenning, P.C. Kamer, E.W. Meijer, P.W. van Leeuwen, “Noncovalently functionalized dendrimers as recyclable catalysts,” J. Am. Chem. Soc. 123(5 September 2001):8453-8458.
5147. D. Astruc, F. Chardac, “Dendritic catalysts and dendrimers in catalysis, “Chem. Rev. 101(September 2001):2991-3024.
5148. A.V. Davis, M. Driffield, D.K. Smith, “A dendritic active site: catalysis of the Henry reaction,” Org. Lett. 3(4 October 2001):3075-3078.
5149. G. Rodriguez, M. Lutz, A.L. Spek, K.G. Van, “New mono- and tricyclopalladated dendritic systems with encapsulated catalytic sites,” Chemistry 8(4 January 2002):45-57.
5150. A. Cordova, K.D. Janda, “Synthesis and catalytic antibody functionalization of dendrimers,” J. Am. Chem. Soc. 123(29 August 2001):8248-8259.
5151. M. Beier, J.D. Hoheisel, “Versatile derivatisation of solid support media for covalent bonding on DNA-microchips,” Nucleic Acids Res. 27(1 May 1999):1970-1977; http://nar.oupjournals.org/cgi/content/full/27/9/1970
5152. R.L. Stears, R.C. Getts, S.R. Gullans, “A novel, sensitive detection system for high-density microarrays using dendrimer technology,” Physiol. Genomics 3(9 August 2000):93-99; http://physiolgenomics.physiology.org/cgi/content/full/3/2/93
5153. R. Benters, C.M. Niemeyer, D. Wohrle, “Dendrimer-activated solid supports for nucleic acid and protein microarrays,” Chembiochem. 2(3 September 2001):686-694.
5154. R. Benters, C.M. Niemeyer, D. Drutschmann, D. Blohm, D. Wohrle, “DNA microarrays with PAMAM dendritic linker systems,” Nucleic Acids Res. 30(15 January 2002):E10.
5155. A.J. Khopade, F. Caruso, P. Tripathi, S. Nagaich, N.K. Jain, “Effect of dendrimer on entrapment and release of bioactive from liposomes,” Int. J. Pharm. 232(31 January 2002):157-162.
5156. A.T. Florence, T. Sakthivel, I. Toth, “Oral uptake and translocation of a polylysine dendrimer with a lipid surface,” J. Control Release 65(1 March 2000):253-259.
5157. R. Wiwattanapatapee, B. Carreno-Gomez, N. Malik, R. Duncan, “Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: a potential oral delivery system?” Pharm. Res. 17(August 2000):991-998.
5158. F. Tajarobi, M. El-Sayed, B.D. Rege, J.E. Polli, H. Ghandehari, “Transport of poly amidoamine dendrimers across Madin-Darby canine kidney cells,” Int. J. Pharm. 215(14 March 2001):263-267.
5159. A.T. Florence, N. Hussain, “Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas,” Adv. Drug Deliv. Rev. 50(1 October 2001):S69-S89 (Suppl 1).
5160. O.L. Padilla De Jesus, H.R. Ihre, L. Gagne, J.M. Frechet, F.C. Szoka Jr., “Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation,” Bioconjug. Chem. 13(May-June 2002):453-461.
5161. A. Vargas-Berenguel, F. Ortega-Caballero, F. Santoyo-Gonzalez, J.J. Garcia-Lopez, J.J. Gimenez-Martinez, L. Garcia-Fuentes, E. Ortiz-Salmeron, “Dendritic galactosides based on a beta-cyclodextrin core for the construction of site-specific molecular delivery systems: synthesis and molecular recognition studies,” Chemistry 8(15 February 2002):812-827.
5162. J.M. Frechet, “Functional polymers and dendrimers: reactivity, molecular architecture, and interfacial energy,” Science 263(25 March 1994):1710-1715.
5163. J.F. Kukowska-Latallo, A.U. Bielinska, J. Johnson, R. Spindler, D.A. Tomalia, J.R. Baker, Jr., “Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers,” Proc. Natl. Acad. Sci. (USA) 93(14 May 1996):4897-4902.
5164. J.F. Kukowska-Latallo, E. Raczka, A. Quintana, C. Chen, M. Rymaszewski, J.R. Baker, Jr., “Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector,” Hum. Gene Ther. 11(1 July 2000):1385-1395.
5165. J.J. Landers, Z. Cao, I. Lee, L.T. Piehler, P.P. Myc, A. Myc, T. Hamouda, A.T. Galecki, J.R. Baker Jr., “Prevention of influenza pneumonitis by sialic acid-conjugated dendritic polymers,” J. Infect. Dis. 186(1 November 2002):1222-1230; J.D. Reuter, A. Myc, M.M. Hayes, Z. Gan, R. Roy, D. Qin, R. Yin, L.T. Piehler, R. Esfand, D.A. Tomalia, J.R. Baker, Jr., “Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers,” Bioconjug. Chem. 10(March-April 1999):271-278.
5166. R. Esfand, D.A. Tomalia, “Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications,” Drug Discov. Today 6(1 April 2001):427-436.
5167. D.I. Axel, I. Spyridopoulos, R. Riessen, H. Runge, R. Viebahn, K.R. Karsch, “Toxicity, uptake kinetics and efficacy of new transfection reagents: increase of oligonucleotide uptake,” J. Vasc. Res. 37(July-August 2000):221-234, 303-304 (discussion).
5168. G.A. Brazeau, S. Attia, S. Poxon, J.A. Hughes, “In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery,” Pharm. Res. 15(May 1998):680-684.
5169. B. Klajnert, M. Bryszewska, “Fluorescence studies on PAMAM dendrimers interactions with bovine serum albumin,” Bioelectrochemistry 55(January 2002):33-35; P. Singh, “Terminal groups in Starburst dendrimers: activation and reactions with proteins,” Bioconjug. Chem. 9(January-February 1998):54-63.
5170. J.O. Bustamante, E.R. Michelette, J.P. Geibel, J.A. Hanover, T.J. McDonnell, D.A. Dean, “Dendrimer-assisted patch-clamp sizing of nuclear pores,” Pflugers Arch. 439(April 2000):829-837.
5171. C. Plank, K. Mechtler, F.C. Szoka Jr., E. Wagner, “Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery,” Hum. Gene Ther. 7(1 August 1996):1437-1446.
5172. M. El-Sayed, M.F. Kiani, M.D. Naimark, A.H. Hikal, H. Ghandehari, “Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium,” Pharm. Res. 18(January 2001):23-28.
5173. T. Sakthivel, I. Toth, A.T. Florence, “Distribution of a lipidic 2.5 nm diameter dendrimer carrier after oral administration,” Int. J. Pharm. 183(10 June 1999):51-55.
5174. M. Kawase, N. Kurikawa, N. Miura, T. Shiomi, C. Ozawa, S. Higashiyama, T. Mizoguchi, K. Yagi, “Immobilization of ligand-modified polyamidoamine dendrimer for cultivation of hepatoma cells,” Artif. Organs 24(January 2000):18-22.
5175. D. Felder, J.L. Gallani, D. Guillon, B. Heinrich, J.F. Nicoud, J.F. Nierengarten, “Investigations of thin films with amphiphilic dendrimers bearing peripheral fullerene subunits,” Angew. Chem. Int. Ed. Engl. 39(January 2000):201-204.
5176. M.X. Tang, F.C. Szoka, “The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes,” Gene Ther. 4(August 1997):823-832.
5177. A. Bielinska, J.F. Kukowska-Latallo, J. Johnson, D.A. Tomalia, J.R. Baker Jr., “Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers,” Nucleic Acids Res. 24(1 June 1996):2176-2182; http://nar.oupjournals.org/cgi/content/full/24/11/2176
5178. V. Helin, M. Gottikh, Z. Mishal, F. Subra, C. Malvy, M. Lavignon, “Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell culture,” Biochem. Pharmacol. 58(1 July 1999):95-107.
5179. H. Yoo, R.L. Juliano, “Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers,” Nucleic Acids Res. 28(1 November 2000):4225-4231.
5180. N. Sato, H. Kobayashi, T. Saga, Y. Nakamoto, T. Ishimori, K. Togashi, Y. Fujibayashi, J. Konishi, M.W. Brechbiel, “Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice,” Clin. Cancer Res. 7(November 2001):3606-3612.
5181. R. Delong, K. Stephenson, T. Loftus, M. Fisher, S. Alahari, A. Nolting, R.L. Juliano, “Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery,” J. Pharm. Sci. 86(June 1997):762-764.
5182. S.K. Alahari, R. DeLong, M.H. Fisher, N.M. Dean, P. Viliet, R.L. Juliano, “Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression,” J. Pharmacol. Exp. Ther. 286(July 1998):419-428; http://jpet.aspetjournals.org/cgi/content/full/286/1/419
5183. C.R. Dass, T. Su, “Particle-mediated intravascular delivery of oligonucleotides to tumors: associated biology and lessons from genotherapy,” Drug Deliv. 8(October-December 2001):191-213.
5184. C.R. Dass, “Vehicles for oligonucleotide delivery to tumours,” J. Pharm. Pharmacol. 54(January 2002):3-27.
5185. S. Kasai, H. Nagasawa, M. Shimamura, Y. Uto, H. Hori, “Design and synthesis of antiangiogenic/heparin-binding arginine dendrimer mimicking the surface of endostatin,” Bioorg. Med. Chem. Lett. 12(25 March 2002):951-954.
5186. M. Kawase, T. Shiomi, H. Matsui, Y. Ouji, S. Higashiyama, T. Tsutsui, K. Yagi, “Suppression of apoptosis in hepatocytes by fructose-modified dendrimers,” J. Biomed. Mater. Res. 54(15 March 2001):519-524.
5187. M.M. Palcic, H. Li, D. Zanini, R.S. Bhella, R. Roy, “Chemoenzymatic synthesis of dendritic sialyl Lewis(x),” Carbohydr. Res. 305(December 1997):433-442.
5188. K. Rittner, A. Benavente, A. Bompard-Sorlet, F. Heitz, G. Divita, R. Brasseur, E. Jacobs, “New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo,” Mol. Ther. 5(February 2002):104-114.
5189. S.H. Battah, C.E. Chee, H. Nakanishi, S. Gerscher, A.J. MacRobert, C. Edwards, “Synthesis and biological studies of 5-aminolevulinic acid-containing dendrimers for photodynamic therapy,” Bioconjug. Chem. 12(November-December 2001):980-988.
5190. R.F. Barth, D.M. Adams, A.H. Soloway, F. Alam, M.V. Darby, “Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy,” Bioconjug. Chem. 5(January-February 1994):58-66.
5191. L. Liu, R.F. Barth, D.M. Adams, A.H. Soloway, R.A. Reisfeld, “Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors,” J. Hematother. 4(October 1995):477-483.
5192. J. Capala, R.F. Barth, M. Bendayan, M. Lauzon, D.M. Adams, A.H. Soloway, R.A. Fenstermaker, J. Carlsson, “Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors,” Bioconjug. Chem. 7(January-February 1996):7-15.
5193. H. Kobayashi, N. Sato, T. Saga, Y. Nakamoto, T. Ishimori, S. Toyama, K. Togashi, J. Konishi, M.W. Brechbiel, “Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity,” Eur. J. Nucl. Med. 27(September 2000):1334-1339.
5194. P. Rajananthanan, G.S. Attard, N.A. Sheikh, W.J. Morrow, “Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses,” Vaccine 17(26 February 1999):715-730.
5195. F. Chaves, J.C. Calvo, C. Carvajal, Z. Rivera, L. Ramirez, M. Pinto, M. Trujillo, F. Guzman, M.E. Patarroyo, “Synthesis, isolation and characterization of Plasmodium falciparum antigenic tetrabranched peptide dendrimers obtained by thiazolidine linkages,” J. Pept. Res. 58(October 2001):307-316.
5196. J.P. Thompson, C.L. Schengrund, “Inhibition of the adherence of cholera toxin and the heat-labile enterotoxin of Escherichia coli to cell-surface GM1 by oligosaccharide-derivatized dendrimers,” Biochem. Pharmacol. 56(1 September 1998):591-597; “Oligosaccharide-derivatized dendrimers: defined multivalent inhibitors of the adherence of the cholera toxin B subunit and the heat labile enterotoxin of E. coli to GM1,” Glycoconj. J. 14(November 1997):837-845.
5197. N. Malik, E.G. Evagorou, R. Duncan, “Dendrimer-platinate: a novel approach to cancer chemotherapy,” Anticancer Drugs 10(September 1999):767-776.
5198. H. Maruyama-Tabata, Y. Harada, T. Matsumura, E. Satoh, F. Cui, M. Iwai, M. Kita, S. Hibi, J. Imanishi, T. Sawada, O. Mazda, “Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer,” Gene Ther. 7(January 2000):53-60.
5199. Y. Harada, M. Iwai, S. Tanaka, T. Okanoue, K. Kashima, H. Maruyama-Tabata, H. Hirai, E. Satoh, J. Imanishi, O. Mazda, “Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer,” Cancer Gene Ther. 7(January 2000):27-36.
Last updated on 16 April 2004